Published in

Mary Ann Liebert, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 5(27), p. 329-340

DOI: 10.1089/jamp.2013.1099

Links

Tools

Export citation

Search in Google Scholar

Evaluation of In Vitro and In Vivo Flow Rate Dependency of Budesonide/Formoterol Easyhaler®

Journal article published in 2014 by L. Pekka Malmberg, Mark L. Everard ORCID, Jussi Haikarainen, Satu Lähelmä
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background: The Easyhaler® (EH) device-metered dry powder inhaler containing budesonide and formoterol is being developed for asthma and chronic obstructive pulmonary disease (COPD). As a part of product optimization, a series of in vitro and in vivo studies on flow rate dependency were carried out.